Xilinx to Demonstrate 400G OTN Single-Chip Applications at WDM Conference 2013

Xilinx, Inc. will demonstrate 400G (4x100G) OTN single-chip applications based on its All Programmable Virtex®-7 FPGAs and SmartCORE™ IP portfolio. These demonstrations highlight Xilinx's commitment to helping customers scale their networks and deliver significant end-product differentiation.

Optimized for high speed and low power, Xilinx OTN solutions make it possible for networks to be ever smarter and more programmable, configurable and adaptable. Visit Xilinx (stand #21) at WDM 2013 in Monaco from June 17-20, at the Grimaldi Forum to learn more.

Xilinx Booth demonstrations
4x 100G OTN Transponder on a single Virtex-7 FPGA

  • This demonstration showcases the Xilinx 400G capacity OTN one-chip solution and features 13.1 Gbps (GTH) transceivers that provide robust performance at line rates that exceed ASSP and competitive offerings. This compact, cost-effective OTN solution incorporates fully-featured 4x 100G Transponder SmartCORE IPs, enabling customers to build smarter solutions that address their market needs for 100G and 400G+ line cards.

High Density 100G Line Card Direct Connection to Finisar CFP2 Optical Modules

  • Xilinx will demonstrate interoperability between its Virtex-7 HT FPGA integrating up to 16x 28 Gbps (GTZ) transceivers and a Finisar CFP2 optical module running at 25.7 Gbps. This demonstration illustrates 2X the 100G port density over the current CFP optical module and showcases real-world integration of 100G networking systems which result in reduced footprint, power and cost.

Xilinx Panels & Presentations
Wednesday, June 19, 2013

  • Panel - Connecting the Dots from Services to Network from Systems to Components - What can be done to stop margin compression? Gilles Garcia, Director, Communications Business Unit, Xilinx

Thursday, June 20, 2013

  • Presentation – All Programmable Technologies for 400G Smart Optical Transport Networks, Gilles Garcia, Director, Communications Business Unit, Xilinx

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.